183 related articles for article (PubMed ID: 32206108)
1. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Chen L; Wang Z; Xu Q; Liu Y; Chen L; Guo S; Wang H; Zeng K; Liu J; Zeng S; Yu L
Theranostics; 2020; 10(8):3562-3578. PubMed ID: 32206108
[No Abstract] [Full Text] [Related]
2. Regulation of
Zhu Q; Yu L; Qin Z; Chen L; Hu H; Zheng X; Zeng S
Epigenetics; 2019 Aug; 14(8):791-803. PubMed ID: 31088315
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Liu Y; Zheng X; Yu Q; Wang H; Tan F; Zhu Q; Yuan L; Jiang H; Yu L; Zeng S
Sci Transl Med; 2016 Jul; 8(348):348ra97. PubMed ID: 27440728
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
5. Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells.
Ueda K; Hosokawa M; Iwakawa S
Biol Pharm Bull; 2015; 38(8):1113-9. PubMed ID: 26235575
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
[No Abstract] [Full Text] [Related]
7. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
[TBL] [Abstract][Full Text] [Related]
8. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.
Visentin M; Torozi A; Gai Z; Häusler S; Li C; Hiller C; Schraml PH; Moch H; Kullak-Ublick GA
Drug Metab Dispos; 2018 Aug; 46(8):1129-1136. PubMed ID: 29794161
[TBL] [Abstract][Full Text] [Related]
9. Monophosphorylation by deoxycytidine kinase affects apparent cellular uptake of decitabine in HCT116 colon cancer cells.
Ueda K; Masuda A; Fukuda M; Tanaka S; Hosokawa M; Iwakawa S
Drug Metab Pharmacokinet; 2017 Dec; 32(6):301-310. PubMed ID: 29174536
[TBL] [Abstract][Full Text] [Related]
10. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
11. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
12. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia contributes to galectin-3 expression in renal carcinoma cells.
Gu X; Meng H; Wang J; Wang R; Cao M; Liu S; Chen H; Xu Y
Eur J Pharmacol; 2021 Jan; 890():173637. PubMed ID: 33065093
[TBL] [Abstract][Full Text] [Related]
14. VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinoma.
Shang D; Xian S; Han T; Li X; Liu Y
J BUON; 2017; 22(2):500-507. PubMed ID: 28534376
[TBL] [Abstract][Full Text] [Related]
15. Myoglobin expression in renal cell carcinoma is regulated by hypoxia.
Behnes CL; Bedke J; Schneider S; Küffer S; Strauss A; Bremmer F; Ströbel P; Radzun HJ
Exp Mol Pathol; 2013 Dec; 95(3):307-12. PubMed ID: 24076247
[TBL] [Abstract][Full Text] [Related]
16. Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma.
Chiu CF; Park JM; Chen HH; Mau CZ; Chen PS; Su YH; Chen HA; Liu YR; Hsieh TH; Chiu CC; Hung SW; Kuo CY; Chen YM; Chang CF
Biomed Pharmacother; 2022 Sep; 153():113520. PubMed ID: 36076515
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
18. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
[TBL] [Abstract][Full Text] [Related]
19. VHL-TGFBI signaling is involved in the synergy between 5-aza-2'-deoxycytidine and paclitaxel against human renal cell carcinoma.
Shang D; Xian S; Han T; Li X; Liu Y
J BUON; 2017; 22(4):1038-1045. PubMed ID: 28952225
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Mol Cancer Ther; 2009 May; 8(5):1045-54. PubMed ID: 19383845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
